What will a future that includes psychedelic-assisted therapy look like? Elizabeth Nielson, PhD, Co-Founder at Fluence, stresses that healthcare professionals first need to understand that “services provided in Oregon under Measure 109, and in the future in Colorado under the NMHA, are not part of the existing healthcare system. Although there are some similarities in terms of professional licensure and responsibility, these laws establish a new license type with its own regulations.” 

She believes more and more opportunities will arise for caregivers to provide psychedelic therapy and related services “within their existing scope of practice, including psychedelic harm reduction and integration, ketamine-assisted therapy, and eventually will likely include FDA-approved psychedelic therapies.”